Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

We need safe, affordable drugs to fight coronaviruses effectively.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

Balancing testosterone may reduce COVID-19 severity.

A new delivery system makes Curcumin more effective and safer against viruses.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Raltegravir may cause hair loss in some patients.

Certain alkaloids could help create new coronavirus drugs.

Cepharanthine could be a strong antiviral against COVID-19.

Researchers found several compounds that could potentially treat Zika virus.

The medication lopinavir-ritonavir may cause severe hair loss.

Six existing drugs may help block virus entry in COVID-19.